There is currently no generic Estring approved in the United States. Although all of the patents for the medication have expired, no generic versions are expected to become available any time soon. There may be companies out there claiming to sell generic Estring; however, these products may be fake, substandard, and potentially dangerous.
Generic Estring: An Overview
Estring® (estradiol vaginal ring) is a prescription hormone replacement medication used to treat vaginal menopause symptoms, such as vaginal dryness, itching, or burning, and urinary menopause symptoms, including painful or urgent urination. Estring is a small, flexible ring that is inserted vaginally and left in place for up to 90 days.
Estring is made by Pfizer, Inc. There are currently no generic versions of the drug approved in the United States. However, if you search the Internet for "generic Estring," you may find a number of companies selling it or claiming to sell it. The fact is that these medicines may be fake, substandard, and potentially dangerous. Generic Estring may be available from another country, but there is really no way of knowing whether you are getting genuine Estring. Therefore, you should not buy any generic Estring until there is an approved generic version available.
Why Isn't Generic Estring Available?
It is not entirely clear why there are no generic versions of Estring, as there are no unexpired patents for this medication. Perhaps it may not be profitable enough for a manufacturer to make a generic version. Or, it is possible that it may be too difficult for a generic manufacturer to make a vaginal estradiol ring that is identical to Estring.
When Will Generic Estring Be Available?
This is difficult to predict. There may never be any generic versions of Estring. At this point, generic Estring is not expected to become available in the immediate future.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Estring [package insert]. New York, NY: Pfizer, Inc.;2007 December.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: Approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed April 28, 2008.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click